Name: 글로벌 시장 동향
SKU: MD8611
Availability: InStock

보고서 요약(국문)

보고서 개요
전 세계 근막절개술 시장은 2023년 41억 5천만 달러에 달했으며, 2024년부터 2031년까지 연평균 6.3%의 성장률을 보이며 2031년에는 66억 8천만 달러에 이를 것으로 예상됩니다.
근막절개술은 조직이나 근육 부위의 혈액 순환 장애로 인한 긴장이나 압력을 완화하기 위해 근막을 절개하는 외과적 시술입니다. 급성 구획 증후군 치료에 사용될 경우 사지 보존에 도움이 되는 시술이며, 만성 구획 스트레스 증후군 치료에도 사용되기도 합니다. 이 시술은 성공률이 매우 높으며, 가장 흔한 문제는 주변 신경 손상입니다.
시술 전 의사는 국소 마취 또는 전신 마취를 시행합니다. 외과의는 영향을 받은 근육 구획 위쪽에 절개를 하여 두꺼운 결합 조직인 근막을 열어 압력을 완화하고 근육과 신경으로의 혈류를 증가시킵니다. 여러 근육이 영향을 받은 경우 하나 이상의 절개가 필요할 수 있습니다.

시장 동향: 주요 동인
구획증후군 유병률 증가
전 세계 근막절개술 시장 수요는 여러 요인에 의해 주도되고 있습니다. 구획증후군 유병률 증가가 시장 성장을 견인하고 있습니다.
또한, 기술 발전으로 치료 수요가 증가할 것으로 예상됩니다. 예를 들어, 미국 국립보건원(NIH)에 따르면 급성 구획증후군의 발생률은 남성 10만 명당 7.3명, 여성 10만 명당 0.7명으로 추정되며, 대부분 외상 후에 발생합니다. 경골 간부 골절은 급성 구획증후군의 가장 흔한 원인이며, 발생률은 1~10%입니다.
급성 구획증후군은 35세 미만 남성에게 더 흔하게 발생하는데, 이는 구획 내 근육량이 상대적으로 많고 고에너지 외상에 노출될 가능성이 높기 때문일 수 있습니다. 혈우병과 같은 출혈성 질환 환자는 급성 구획증후군 발생 위험이 더 높습니다. 소아 백혈병 환자에서 급성 외상 없이 급성 구획 증후군이 발생한 사례가 보고되었습니다.
제한 요인
시술과 관련된 높은 비용 및 새로운 치료법 승인을 위한 엄격한 규제 요건과 같은 요인들이 시장 성장을 저해할 것으로 예상됩니다.
시장 세분화 분석
전 세계 근막절개술 시장은 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
피부 이식 근막절개술 기구(STSG) 부문은 전 세계 근막절개술 시장 점유율의 약 58%를 차지했습니다.
피부 이식 근막절개술 기구(STSG) 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이 부문에서는 정부 규제 개발과 민간 제조업체의 연구 자금 증가가 시장 성장을 견인할 것입니다.
예를 들어, 2021년 4월 미국 식품의약국(FDA)은 Chemence Medical의 재설계된 Exofin 융합 피부 봉합 시스템에 510(k) 승인을 부여했습니다. 엑소핀 퓨전은 자가 접착성 유연 메쉬 스트립과 빠르게 경화되는 2-옥틸 시아노아크릴레이트 국소 접착제를 제공하여 절개 부위를 덮고 밀봉하는 동시에 즉각적인 미생물 차단막을 형성하여 감염을 예방합니다.
시장 지역 분석
북미는 전 세계 근막절개술 시장 점유율의 약 42%를 차지했습니다.
북미 지역은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 이 지역에서 구획 증후군의 발생률 증가, 기술 발전, 그리고 사람들의 인식 향상이 시장 성장을 견인하고 있습니다.
예를 들어, clevelandclinic.org에 따르면 전문가들은 미국에서 매년 10만 명당 10명 미만이 급성 구획 증후군을 경험하는 것으로 추정합니다. 그러나 특정 유형의 골절(뼈가 부러진 경우)이 있는 사람들에게서는 훨씬 더 흔하게 발생합니다. 예를 들어, 연구에 따르면 경골 골절 환자의 약 10%가 구획 증후군을 앓는 것으로 추정됩니다.

예를 들어, 2020년 2월 바이오프린팅 회사인 T&R Biofab은 존슨앤존슨 의료기기 회사인 Ethicon Llc., Inc.와 새로운 협력 계약을 발표했습니다. 이 파트너십은 상처 치료, 재건 수술 등에 사용될 3D 바이오프린팅 연조직 지지체를 개발하는 것을 목표로 합니다.
시장 세분화
기구별
• 피부 이식 근막 절개술 기구(STSG)
• 음압 상처 치료 근막 절개술 기구(NPWT)
• 혈관 링 기법 근막 절개술 기구
• 지속적 외부 조직 확장 근막 절개술 기구(CETE)
• 기타
적용 분야별
• 족저근막염
• 급성 구획 증후군
• 만성 구획 증후군
• 기타
최종 사용자별
• 병원
• 전문 클리닉
• 외래 및 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 기타 아시아 태평양
• 중동 및 아프리카
시장 경쟁 구도
글로벌 근막절개술 시장의 주요 글로벌 업체로는 Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., Southmedic Inc. 등이 있습니다.
주요 개발 사항
• 2022년 6월, 조직 치유 기술 전문 기업인 Advanced Medical Solutions는 더 긴 상처를 봉합할 수 있는 새로운 기기인 LiquiBand XL에 대해 FDA 510(k) 승인을 받았습니다. 이 기기는 상처를 봉합하는 데 사용되는 수술용 메쉬와 봉합 부위를 강화하고 감염을 예방하는 데 사용되는 LiquiBand 접착제로 구성됩니다.

• 2024년 5월, 수술용 칼날, 메스 및 혁신적인 의료 기기 제조업체인 SouthMedic은 Nano Surgical과 파트너십을 체결하여 캐나다에서 Lumohs MD No. 3 조명 메스 손잡이의 독점 유통업체가 되었다고 발표했습니다.

보고서 구매 이유

• 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 근막절개술 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악하기 위해

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴하기 위해
• 모든 세그먼트를 포함한 글로벌 근막절개술 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트 제공

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서 제공

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 Excel 파일 제공

글로벌 근막절개술 시장 보고서는 약 51개의 표, 54개의 그림, 181페이지 분량으로 구성됩니다.
주요 고객 (2024년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Report Overview
The Global Fasciotomy Market reached US$ 4.15 billion in 2023 and is expected to reach US$ 6.68 billion by 2031, growing at a CAGR of 6.3% during the forecast period 2024-2031.
Fasciotomy is a surgical procedure where the fascia is cut to relieve tension or pressure to treat the resulting loss of circulation to an area of tissue or muscle. Fasciotomy is a limb-saving procedure when used to treat acute compartment syndrome. It is also sometimes used to treat chronic compartment stress syndrome. The procedure has a very high rate of success, with the most common problem being accidental damage to a nearby nerve.
Before the procedure, doctors administer regional or general anesthesia. The surgeon makes an incision above the affected muscle compartment, opening the restrictive fascia—thick sheets of connective tissue—to relieve pressure and increase blood flow to muscles and nerves. More than one incision may be required if multiple muscles are affected.
Market Dynamics: Drivers
Increasing prevalence of compartment syndrome
The demand for the global fasciotomy market is driven by multiple factors. The rising prevalence of compartment syndrome propels the market growth.
Furthermore, the demand for treatment will be fueled by technological advancements. For instance, according to nih.gov, The incidence of acute compartment syndrome is estimated to be 7.3 per 100,000 in males and 0.7 per 100,000 in females, with the majority of cases occurring after trauma. Tibial shaft fracture is the most common cause of acute compartment syndrome and is associated with a 1 to 10 percent incidence of acute compartment syndrome.
Acute compartment syndrome occurs more commonly in males younger than 35, which may be due to a larger relative intracompartmental muscle mass and increased likelihood of being involved in high-energy trauma. Patients with bleeding diathesis, such as hemophilia, are at greater risk for acute compartment syndrome. Cases of acute compartment syndrome have been reported without acute precipitating trauma in pediatric leukemia.
Restraints
Factors such as high costs associated with the procedure and stringent regulatory requirements for the approval of new treatments are expected to hamper the market.
Market Segment Analysis
The global fasciotomy market is segmented based on type, application, end-user, and region.
The segment skin graft fasciotomy instrument (STSG) accounted for approximately 58% of the global fasciotomy market share
The skin graft fasciotomy instrument (STSG) segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and rising funds for private manufacturers for research would drive this market.
For instance, in April 2021, the US Food and Drug Administration (FDA) granted 510(k) approval to Chemence Medical’s redesigned Exofin fusion skin closure system. Exofin fusion offers a self-adhering, flexible mesh strip and a rapidly curing 2-octyl cyanoacrylate topical adhesive, which covers and seals incisions while also creating an immediate microbial barrier to protect against infections.
Market Geographical Analysis
North America accounted for approximately 42% of the global fasciotomy market share
North America region is expected to hold the largest market share over the forecast period. The rising incidence of compartment syndrome, technological advancements, and growing awareness among people, in this region, help to propel the market.
For instance, according to clevelandclinic.org, experts estimate that fewer than 10 in every 100,000 people in the U.S. experience acute compartment syndrome each year. However, it’s much more common in people who have some types of bone fractures (broken bones). For example, studies estimate that around 10% of people who break their tibia develop compartment syndrome.
For instance, in February 2020, Bioprinting company T&R Biofab announced a new collaboration agreement with Ethicon Llc., Inc., a Johnson & Johnson Medical Device Company. The partnership aims to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery, and more.
Market Segmentation
By Instrument
• Skin Graft Fasciotomy Instrument (STSG)
• Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT)
• Vascular Ring Technique Fasciotomy Instrument
• Continuous External Tissue Expansion Fasciotomy Instrument (CETE)
• Others
By Application
• Plantar Fasciitis
• Acute Compartment Syndrome
• Chronic Compartment Syndrome
• Others
By End-User
• Hospitals
• Specialty Clinics
• Ambulatory and Surgery Centers
• Others
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Market Competitive Landscape
The major global players in the global fasciotomy market include Zipline Medical Inc., Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc., and Southmedic Inc. among others.
Key Developments
• In June 2022, Advanced Medical Solutions, a specialist in tissue-healing technologies, received FDA 510(k) approval for LiquiBand XL, a new device that can close longer wounds. The device consists of a surgical mesh which is used to close the wound and LiquiBand glue which is used to strengthen the closure and prevent infection.
• In May 2024, SouthMedic, a leading manufacturer of surgical blades, scalpels, and innovative medical devices, announced its partnership with Nano Surgical to become the exclusive master distributor of Lumohs MD no. 3 Lighted Scalpel Handles in Canada.
Why Purchase the Report?
• To visualize the global fasciotomy market segmentation based on type, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global fasciotomy market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The global fasciotomy market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Compartment Syndrome
4.1.1.2. Technological Advancements
4.1.2. Restraints
4.1.2.1. High Cost of Procedure
4.1.2.2. Stringent Regulatory Requirements
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Skin Graft Fasciotomy Instrument*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Negative Pressure Wound Treatment Fasciotomy Instrument
6.4. Vascular Ring Technique Fasciotomy Instrument
6.5. Continuous External Tissue Expansion Fasciotomy Instrument
6.6. Vistide
6.7. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Plantar Fascitis*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute Compartment Syndrome
7.4. Chronic Compartment Syndrome
7.5. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory and Surgery Centers
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Zipline Medical Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Stryker Corporation
11.3. DermaClose
11.4. Terumo Corporation
11.5. Merit Medical Systems
11.6. Ethicon Llc.
11.7. Cardinal Health
11.8. 3M
11.9. Biopro Inc.
11.10. Southmedic Inc. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Zipline Medical Inc., 4.	Key Developments, Stryker Corporation, DermaClose, Terumo Corporation, Merit Medical Systems, Ethicon Llc., Cardinal Health, 3M, Biopro Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Fasciotomy Market Value, By Instrument, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Fasciotomy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Fasciotomy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Fasciotomy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Fasciotomy Market Value, By Instrument, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 7 Global Fasciotomy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Fasciotomy Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Fasciotomy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Fasciotomy Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 14 North America Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Fasciotomy Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 18 South America Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Fasciotomy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 22 Europe Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Fasciotomy Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Fasciotomy Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East and Africa Fasciotomy Market Value, By Instrument, 2022-2031 (US$ Million)

Table 30 Middle East and Africa Fasciotomy Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East and Africa Fasciotomy Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Middle East and Africa Fasciotomy Market Value, By Country, 2022-2031 (US$ Million)

Table 33 Zipline Medical Inc.: Overview

Table 34 Zipline Medical Inc.: Product Portfolio

Table 35 Zipline Medical Inc.: Key Developments

Table 36 Stryker Corporation: Overview

Table 37 Stryker Corporation: Product Portfolio

Table 38 Stryker Corporation: Key Developments

Table 39 DermaClose: Overview

Table 40 DermaClose: Product Portfolio

Table 41 DermaClose: Key Developments

Table 42 Terumo Corporation: Overview

Table 43 Terumo Corporation: Product Portfolio

Table 44 Terumo Corporation: Key Developments

Table 45 Merit Medical Systems: Overview

Table 46 Merit Medical Systems: Product Portfolio

Table 47 Merit Medical Systems: Key Developments

Table 48 Ethicon Llc.: Overview

Table 49 Ethicon Llc.: Product Portfolio

Table 50 Ethicon Llc.: Key Developments

Table 51 Cardinal Health: Overview

Table 52 Cardinal Health: Product Portfolio

Table 53 Cardinal Health: Key Developments

Table 54 3M: Overview

Table 55 3M: Product Portfolio

Table 56 3M: Key Developments

Table 57 Biopro Inc.: Overview

Table 58 Biopro Inc.: Product Portfolio

Table 59 Biopro Inc.: Key Developments

Table 60 Southmedic Inc.: Overview

Table 61 Southmedic Inc.: Product Portfolio

Table 62 Southmedic Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 3 Global Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 4 Global Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 5 Global Fasciotomy Market Share, By Region, 2023 & 2031 (%)

Figure 6 Global Fasciotomy Market Y-o-Y Growth, By Instrument, 2023-2031 (%)

Figure 7 Skin Graft Fasciotomy Instrument (STSG) Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 8 Negative Pressure Wound Treatment Fasciotomy Instrument (NPWT) Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 9 Vascular Ring Technique Fasciotomy Instrument Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 10 Continuous External Tissue Expansion Fasciotomy Instrument (CETE) Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 11 Others Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 12 Global Fasciotomy Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 13 Plantar Fasciitis Application in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 14 Acute Compartment Syndrome Application in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 15 Chronic Compartment Syndrome Application in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 16 Others Application in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 17 Global Fasciotomy Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 18 Hospitals End-User in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 19 Specialty Clinics End-User in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 20 Ambulatory and Surgery Centers End-User in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 21 Others End-User in Global Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 22 Global Fasciotomy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 23 North America Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 24 North America Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 25 North America Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 26 North America Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 27 North America Fasciotomy Market Share, By Country, 2023 & 2031 (%)

Figure 28 South America Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 29 South America Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 30 South America Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 31 South America Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 32 South America Fasciotomy Market Share, By Country, 2023 & 2031 (%)

Figure 33 Europe Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 34 Europe Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 35 Europe Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 36 Europe Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 37 Europe Fasciotomy Market Share, By Country, 2023 & 2031 (%)

Figure 38 Asia-Pacific Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 39 Asia-Pacific Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 40 Asia-Pacific Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 41 Asia-Pacific Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 42 Asia-Pacific Fasciotomy Market Share, By Country, 2023 & 2031 (%)

Figure 43 Middle East and Africa Fasciotomy Market Value, 2022-2031 (US$ Million)

Figure 44 Middle East and Africa Fasciotomy Market Share, By Instrument, 2023 & 2031 (%)

Figure 45 Middle East and Africa Fasciotomy Market Share, By Application, 2023 & 2031 (%)

Figure 46 Middle East and Africa Fasciotomy Market Share, By End-User, 2023 & 2031 (%)

Figure 47 Zipline Medical Inc.: Financials

Figure 48 Stryker Corporation: Financials

Figure 49 DermaClose: Financials

Figure 50 Terumo Corporation: Financials

Figure 51 Merit Medical Systems: Financials

Figure 52 Ethicon Llc.: Financials

Figure 53 Cardinal Health: Financials

Figure 54 3M: Financials

Figure 55 Biopro Inc.: Financials

Figure 56 Southmedic Inc.: Financials

세계 근막절개술 시장 – 2024-2031년

Global Fasciotomy Market - 2024-2031